ATEA PHARMACEUTICALS INC's ticker is AVIR and the CUSIP is 04683R106. A total of 125 filers reported holding ATEA PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.05 and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $114,774 | -16.8% | 38,258 | +3.7% | 0.00% | 0.0% |
| Q2 2023 | $137,999 | +11.9% | 36,898 | +0.2% | 0.00% | 0.0% |
| Q1 2023 | $123,367 | -28.9% | 36,826 | +2.0% | 0.00% | 0.0% |
| Q4 2022 | $173,607 | -15.7% | 36,093 | -0.4% | 0.00% | 0.0% |
| Q3 2022 | $206,000 | -18.9% | 36,224 | +1.4% | 0.00% | -50.0% |
| Q2 2022 | $254,000 | +9.5% | 35,712 | +11.4% | 0.00% | +100.0% |
| Q1 2022 | $232,000 | -24.4% | 32,065 | -6.6% | 0.00% | -50.0% |
| Q4 2021 | $307,000 | -75.2% | 34,322 | -2.9% | 0.00% | -71.4% |
| Q3 2021 | $1,239,000 | +59.5% | 35,349 | -2.3% | 0.01% | +133.3% |
| Q2 2021 | $777,000 | +48.9% | 36,189 | +328.2% | 0.00% | +50.0% |
| Q1 2021 | $522,000 | +48.3% | 8,452 | +0.3% | 0.00% | +100.0% |
| Q4 2020 | $352,000 | – | 8,429 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 2,485,638 | $22,222,000 | 1.76% |
| EcoR1 Capital, LLC | 5,376,134 | $48,063,000 | 1.53% |
| Cormorant Asset Management, LP | 1,679,442 | $15,014,000 | 0.89% |
| CM Management, LLC | 100,000 | $894,000 | 0.68% |
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 596,800 | $5,335,000 | 0.40% |
| PDT Partners, LLC | 278,487 | $2,490,000 | 0.19% |
| Ikarian Capital, LLC | 116,600 | $1,043,000 | 0.16% |
| HighVista Strategies LLC | 20,659 | $185,000 | 0.15% |
| Aristides Capital LLC | 35,132 | $314,000 | 0.14% |
| Parkwood LLC | 71,932 | $643,000 | 0.11% |